ACIP Recommendations for Non-Respiratory Immunizations Remain Largely Unchanged | NCPA 2024
Drug Topics
OCTOBER 27, 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Drug Topics
OCTOBER 27, 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
Drug Topics
JULY 31, 2024
Catch up on important immunization news from the month of July.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
SEPTEMBER 2, 2024
Catch up on important immunization news from the month of August.
Drug Topics
APRIL 17, 2023
At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.
Drug Topics
SEPTEMBER 25, 2024
Catch up on important immunization news from the month of September.
STAT
APRIL 10, 2024
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.
STAT
JULY 10, 2024
But new research asks the question: What if immune cells could be turned back into good guys, and actually help save tissue damaged by autoimmune disease? Lupus is complicated because it wields the body’s own defenses against itself, generating a continuous immune misfire. Read the rest…
STAT
FEBRUARY 14, 2024
The study , published Wednesday in Nature, underscores the importance of never lighting up that first cigarette, based on its conclusion that smoking has much longer harmful effects on immune responses than previously understood. Read the rest…
Pharmacy Times
JANUARY 2, 2024
The new understanding of immune cells could not only contribute to the development of lung disease treatments, but treatments for other organ systems as well.
Drug Topics
APRIL 9, 2024
Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.
Pharmacy Times
JUNE 4, 2024
The immunizing technicians stated they had greater job satisfaction and had a greater sense of being valuable pharmacy members
STAT
MARCH 27, 2024
Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “ twilight of immunity. ” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.
Pharmacy Times
JULY 26, 2024
Study finds traces of “epigenetic scars” on the immune cells of patients who recovered from chronic hepatitis C infection.
STAT
OCTOBER 13, 2023
As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.
STAT
FEBRUARY 28, 2024
The ads, which tell parents to contact their general practitioners if they’ve missed getting their kids immunized, are designed to capture parents’ desires to keep kids safe. Read the rest…
Pharmacy Times
SEPTEMBER 21, 2023
Two separate study findings reported that a subset of dormant CD4+ cells could spontaneously produce HIV RNA and proteins, impacting a patient’s HIV-specific immune responses.
STAT
OCTOBER 6, 2023
If the Covid-19 pandemic has shown us one thing, it is how little we really know about how the human immune system works. Decoding and harnessing the power of the human immune system is one of the great frontiers of biomedicine.
Drug Topics
OCTOBER 21, 2024
Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.
STAT
JUNE 10, 2024
Moderna announced Monday that, in a Phase 3 clinical trial, its combination Covid-19 and influenza vaccine generated stronger immune responses in older adults than individual vaccines that target those viruses.
Pharmacy Times
DECEMBER 13, 2023
Fractional COVID-19 dosing resulted in fewer adverse effects and costs while producing similar immune responses compared to a full dose vaccine.
STAT
MARCH 28, 2024
For scientists who study the human immune system, the penny dropped at different points in the early frenetic months of the Covid-19 pandemic. Looking back now, many marvel at the realization that they witnessed and were able to chronicle something no other scientists had ever actually seen.
STAT
JANUARY 18, 2024
New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.
Drug Topics
MAY 21, 2024
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
STAT
MARCH 21, 2024
This “summer of discovery,” as McKenna called it, brought him back to the immune system. McKenna discussed possibilities with his teenagers and Prometheus’ chief scientific officer.
Pharmacy Times
JULY 30, 2024
Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.
STAT
MAY 21, 2024
Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers.
STAT
NOVEMBER 24, 2023
The evidence presented to the WHO team pointed to what’s sometimes called an immunity gap that was created by the pandemic. But a rapidly organized meeting Thursday between the World Health Organization and health officials in China assuaged much of that concern.
Drug Topics
JULY 16, 2024
COVID-19 patients had reduced absolute granulocyte, monocyte, and lymphocyte counts at 10 months post-infection compared to noninfected individuals.
Drug Topics
OCTOBER 10, 2023
Patients with rheumatoid arthritis had a higher risk of shingles when treated once a day with 4 mg of baricitinib, 100 mg of peficitinib, or 30 mg of upadacitinib.
Pharmacy Times
AUGUST 23, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.
Pharmacy Times
SEPTEMBER 25, 2023
For community pharmacists, cooler temperatures, school buses on the roads and Friday night football are not just signs of a changing season – they are indicators that patients will soon be seeking vaccinations for the 2023-2024 respiratory illness season.
Drug Topics
SEPTEMBER 25, 2023
A new study from Yale School of Medicine and Icahn School of Medicine at Mount Sinai found that patients with long COVID had increased antibodies that help fight different viruses and lower levels of cortisol.
STAT
MARCH 22, 2024
The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals against Covid-19. The drug, known as Pemgarda and marketed by the biotech Invivyd, is the first such drug to become available since the agency pulled AstraZeneca’s Evusheld off the market in January 2023.
Pharmacy Times
AUGUST 15, 2024
RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.
pharmaphorum
MAY 13, 2024
Takeda has made a strong play for a stake in the Alzheimer’s disease market, paying $100 million upfront for an option on AC Immune’s amyloid-targeting immunotherapy. The option fee could be followed by another up to $2.1
Drug Topics
DECEMBER 7, 2022
The shingles vaccine appears to confer long-term immunity, according to research.
Drug Topics
AUGUST 2, 2024
The technology from Diakonos Oncology initiates a natural immune response that targets and eliminates cancer cells by activating cytotoxic TH1 cell signaling pathways.
Pharmacy Times
OCTOBER 28, 2024
Champions for Vaccine Education, Equity, and Progress reported that the majority of pharmacists believe that it is important to prioritize vaccine development and distribution.
Drug Topics
MARCH 27, 2024
mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5 5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine.
Drug Topics
DECEMBER 24, 2023
Vaccine approvals included two immunizations for RSV and a new pentavalent meningococcal shot.
Pharmacy Times
SEPTEMBER 23, 2024
Approved with 3 new indications, bimekizumab-bkzx is the first and only interleukin-17 inhibitor approved for these diseases.
Drug Topics
JUNE 28, 2024
The updates follow the Advisory Committee for Immunization Practice meeting held June 26 to 28, 2024.
STAT
OCTOBER 23, 2023
The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA (..)
Drug Topics
MARCH 26, 2024
Posters presented at the APhA 2024 Annual Meeting and Exposition discussed pharmacist barriers in pediatric immunizations, a novel meningococcal vaccine, and the need for inpatient reviews of vaccination history.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content